Mast cell tryptase (MCT) is a well-known pro-angiogenic mediator [63,74] and it is strongly associated with protease-activated receptor 2 (PAR-2) expression on intestinal cells, thus contributing to tumor progression [9]. The gene discussed is F2RL1; the disease is neoplasm.